[Veno-occlusive disease of the liver]

Malwina Rybicka1, Robert Krysiak, Bogusław Okopień

  • 1Klinika Chorób Wewnetrznych i Farmakologii Klinicznej Katedry Farmakologii Slaskiego Uniwersytetu Medycznego w Katowicach. malwinarybicka@poczta.onet.pl

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|October 13, 2009
PubMed

Insights

Veno-occlusive disease (VOD) obstructs liver blood flow in bone marrow transplant patients, causing serious complications. Early detection and effective treatments are crucial due to high mortality rates in severe cases.

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Vascular Biology

Context:

  • Veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), is a significant complication following hematopoietic stem cell transplantation (HSCT).
  • It is characterized by the occlusion of hepatic sinusoids and small hepatic veins, leading to liver congestion and hepatomegaly.
  • VOD affects bone marrow transplant recipients, with incidence and severity varying based on conditioning regimens and patient factors.

Purpose:

  • To describe the pathophysiology, clinical presentation, grading, and prognostic markers of Veno-occlusive disease (VOD) in bone marrow transplant recipients.
  • To highlight the clinical significance of VOD as a cause of mortality post-transplantation.
  • To emphasize the need for improved VOD prophylaxis and treatment strategies.

Summary:

  • VOD involves obstruction of hepatic sinusoidal and centrolobular venous outflow due to liver vessel endothelial injury.
  • Clinical manifestations include jaundice, portal hypertension, peripheral edema, and weight gain.
  • Disease severity is graded mild, moderate, or severe, with serum bilirubin and weight gain rates serving as key indicators within the first two weeks.

Impact:

  • Severe VOD is a leading cause of mortality in bone marrow transplant survivors.
  • Limited therapeutic options underscore the importance of VOD prophylaxis and the development of more effective treatments.
  • Understanding VOD's clinical markers aids in timely intervention and patient management, potentially improving outcomes.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...